Guardian Biomedical

Guardian BioMedical is a privately held healthcare technology company developing continuous physiologic monitoring solutions for hospital and post-discharge care settings. The company's lead product, PREVIO, is a continuous physiologic intelligence platform designed to detect patient deterioration earlier across medical-surgical units, step-down un... its, and the high-risk 30-day post-discharge transition window. PREVIO passively and continuously monitors patients against their individual physiologic baselines, surfacing only meaningful risk shifts to reduce alarm fatigue and improve clinical decision-making without adding to nursing workload. The platform is designed to give care teams early visibility into deteriorating conditions before escalation to the ICU becomes necessary, and extends coverage through the post-discharge period to support readmission reduction. Guardian BioMedical is pursuing FDA 510(k) clearance and has secured pre-submission feedback, with a HIPAA-compliant architecture certified by third-party auditors. The company is led by founders and operators with prior exits in medical devices, enterprise software, and government health contracts, and is guided by industry advisors with expertise in medicine, biomedical engineering, and healthcare technology.Read More